List of insiders holdings for Solid Biosciences Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
Ultragenyx Pharmaceutical Inc. 10% Owner | 2020-11-06 16:16:00 | 7,825,797 0 | 7,825,797 | Form 13D |
PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD Perceptive Xontogeny Venture Fund LP EDELMAN JOSEPH Director 10% Owner | 2024-11-14 19:59:25 | 6,934,678 0 | 6,934,678 | Form 13D |
PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD Perceptive Xontogeny Venture Fund LP Perceptive Venture Advisors LLC EDELMAN JOSEPH Director 10% Owner | 2024-11-14 19:59:25 | 6,934,678 0 | 6,934,678 | Form 13D |
Boxer Capital LLC Boxer Asset Management Inc. Braslyn Ltd. LEWIS JOSEPH MVA Investors LLC 10% Owner | 2022-02-14 16:40:06 | 5,336,031 0 | 5,336,031 | Form 13G |
Boxer Capital LLC 10% Owner | 2022-02-14 16:40:06 | 5,336,031 0 | 5,336,031 | Form 13G |
Hayeem Gilad David 10% Owner | 2020-02-14 16:39:36 | 4,441,972 0 | 4,441,972 | Form 13G |
RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. RA Capital Nexus Fund L.P. Director 10% Owner | 2024-06-12 18:26:52 | 4,358,478 0 | 4,358,478 | Form 13D |
Koppel Adam Director 10% Owner | 2024-01-12 16:56:49 | 0 4,034,582 | 4,034,582 | Form 4 |
Arnold Matthew Bennett Director | 2020-12-14 16:21:07 | 3,933,429 0 | 3,933,429 | Form 4 |
Bain Capital Life Sciences Investors LLC BCLS SB Investco LP Bain Capital Life Sciences Partners LP Bain Capital Life Sciences Fund II L.P. Bain Capital Life Sciences Investors II LLC BCLS II Investco LP BCLS II Investco (GP) LLC BCIP Life Sciences Associates LP Director 10% Owner | 2024-06-11 20:43:56 | 2,301,955 0 | 2,301,955 | Form 13D |
BCLS II Equity Opportunities GP LLC BCLS II Equity Opportunities LP Director 10% Owner | 2024-01-19 19:23:27 | 0 904,160 | 904,160 | Form 3 |
Cumbo Alexander President and CEO | 2024-02-16 12:01:20 | 360,375 0 | 360,375 | Form 4 |
Ziolkowski Jennifer Lynn CFO, Treasurer & Asst. Secy | 2021-01-29 16:00:11 | 335,636 0 | 335,636 | Form 4 |
Brennan Erin Powers Chief Legal Officer, Secretary | 2022-05-04 16:35:18 | 254,000 0 | 254,000 | Form 4 |
Schneider Joel Solomon Zev Chief Operating Officer | 2022-03-15 17:12:38 | 236,270 0 | 236,270 | Form 4 |
HERSCHA LYNETTE Chief Legal Officer | 2020-07-29 17:28:37 | 176,859 0 | 176,859 | Form 4 |
Howton David T Chief Operating Officer | 2024-02-16 11:28:40 | 176,250 0 | 176,250 | Form 4 |
Marlowe Jennifer CSO | 2024-02-16 11:28:35 | 135,000 0 | 135,000 | Form 4 |
Tan Kevin CFO & Treasurer | 2024-02-16 11:45:38 | 127,500 0 | 127,500 | Form 4 |
SMITH IAN F Director | 2024-10-04 16:05:09 | 112,972 0 | 112,972 | Form 4 |
Hanrahan Jessie Chief Regulatory Officer | 2024-02-16 12:03:56 | 97,500 0 | 97,500 | Form 4 |
Herzich Paul Chief Technology Officer | 2024-02-16 11:02:36 | 92,272 0 | 92,272 | Form 4 |
Amorrortu Pedro Alvaro Chief Operating Officer | 2019-01-25 17:05:42 | 60,000 0 | 60,000 | Form 4 |
Quiroz Jorge Armando Chief Medical Officer | 2019-01-25 17:08:26 | 60,000 0 | 60,000 | Form 4 |
Brooks Gabriel Chief Medical Officer | 2024-10-22 16:05:03 | 40,229 0 | 40,229 | Form 4 |
Stone Adam Leo Director | 2024-11-19 16:20:56 | 34,400 0 | 34,400 | Form 4 |
Keresty Georgia Director | 2024-06-13 16:13:52 | 34,400 0 | 34,400 | Form 4 |
PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH Director 10% Owner | 2024-11-19 16:20:03 | 0 34,400 | 34,400 | Form 4 |
Sullivan Lynne Marie Director | 2024-06-13 16:10:42 | 34,400 0 | 34,400 | Form 4 |
Freed Martin I Director | 2024-06-13 16:10:02 | 34,400 0 | 34,400 | Form 4 |
Nagendran Sukumar Director | 2024-06-13 16:08:01 | 34,400 0 | 34,400 | Form 4 |
Kahn Clare Director | 2024-06-13 16:06:45 | 34,400 0 | 34,400 | Form 4 |
Ganot Ilan Director | 2024-06-13 16:05:32 | 34,400 0 | 34,400 | Form 4 |
DiPalma Stephen J. Interim CFO | 2021-02-01 16:00:09 | 0 30,000 | 30,000 | Form 3 |
Morris Carl Ashley Chief Scientific Officer | 2023-01-31 21:18:53 | 23,460 0 | 23,460 | Form 4 |
Zarur Juan Andrey Director | 2020-01-03 16:31:50 | 10,000 0 | 10,000 | Form 4 |
Huffines Robert Luther Director | 2022-12-15 18:13:42 | 9,650 0 | 9,650 | Form 4 |
JPMORGAN CHASE & CO JPMC Strategic Investments II Corp Former 10% Owner | 2018-01-31 11:08:22 | 0 0 | 0 | Form 4 |